๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of symptomatic diabetic neuropathy

โœ Scribed by Andrew J. M. Boulton

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
88 KB
Volume
19
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pathophysiology and treatment of diabeti
Pathophysiology and treatment of diabetic neuropathy
โœ Dejgaard, A. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 155 KB ๐Ÿ‘ 1 views

The scope of the present review is to describe epidemiology, classification, symptomatology and treatment of diabetic peripheral somatic neuropathy and autonomic neuropathy. Special attention is paid to the use of local anaesthetic agents in painful diabetic neuropathy. Denervation hypersensitivity

Painful diabetic neuropathy: treatment a
Painful diabetic neuropathy: treatment and future aspects
โœ Dan Ziegler ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 96 KB

Around one of three diabetic patients is affected by distal symmetric polyneuropathy (DSP) which represents a major health problem, as it may present with partly excruciating neuropathic pain and is responsible for substantial morbidity and increased mortality. Treatment is based on four cornerstone

A combined treatment for severe diabetic
A combined treatment for severe diabetic neuropathy symptoms
โœ Worsley, A.P.; Allawi, J. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 2 views

## Antibodies to GAD in Diabetic Patients with Chronic Hepatitis C There is a documented relationship between hepatitis C virus (HCV) infection and evidence of autoimmune thyroid disease. (AITD). 1 Furthermore titres of glutamic acid decarboxylase (GAD) antibodies, one of the markers for autoimmun